Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Other Accumulated Expenses (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Other Accumulated Expenses for 14 consecutive years, with $546000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 26.68% to $546000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $546000.0, a 26.68% increase, with the full-year FY2025 number at $546000.0, up 26.68% from a year prior.
  • Other Accumulated Expenses was $546000.0 for Q4 2025 at Lemaitre Vascular, up from $438000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $6.1 million in Q2 2022 to a low of $119000.0 in Q3 2022.
  • A 5-year average of $1.6 million and a median of $434500.0 in 2024 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: crashed 97.78% in 2022, then surged 179.83% in 2023.
  • Lemaitre Vascular's Other Accumulated Expenses stood at $152000.0 in 2021, then skyrocketed by 65.79% to $252000.0 in 2022, then soared by 58.73% to $400000.0 in 2023, then rose by 7.75% to $431000.0 in 2024, then grew by 26.68% to $546000.0 in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Other Accumulated Expenses are $546000.0 (Q4 2025), $438000.0 (Q3 2025), and $380000.0 (Q2 2025).